Seguir
David Moher
David Moher
Ottawa Hospital Research Institute
Dirección de correo verificada de ohri.ca
Título
Citado por
Citado por
Año
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, t PRISMA Group*
Annals of internal medicine 151 (4), 264-269, 2009
179121*2009
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
MJ Page, JE McKenzie, PM Bossuyt, I Boutron, TC Hoffmann, CD Mulrow, ...
bmj 372, 2021
789182021
Cochrane handbook for systematic reviews of interventions
JP Higgins
Cochrane Collaboration and John Wiley & Sons Ltd, 2008
709592008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
A Liberati, DG Altman, J Tetzlaff, C Mulrow, PC Gøtzsche, JPA Ioannidis, ...
Annals of internal medicine 151 (4), W-65-W-94, 2009
529652009
The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials
JP Higgins
The Cochrane Collaboration, 2011
308692011
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
AC Tricco, E Lillie, W Zarin, KK O'Brien, H Colquhoun, D Levac, D Moher, ...
Annals of internal medicine 169 (7), 467-473, 2018
256962018
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Systematic reviews 4, 1-9, 2015
220372015
Meta-analysis of observational studies in epidemiology: a proposal for reporting
DF Stroup, JA Berlin, SC Morton, I Olkin, GD Williamson, D Rennie, ...
Jama 283 (15), 2008-2012, 2000
214952000
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
L Shamseer, D Moher, M Clarke, D Ghersi, A Liberati, M Petticrew, ...
Bmj 349, 2015
126312015
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher, KF Schulz, DG Altman
The lancet 357 (9263), 1191-1194, 2001
10940*2001
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration
JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ...
Annals of internal medicine 147 (8), W-163-W-194, 2007
107642007
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
BJ Shea, BC Reeves, G Wells, M Thuku, C Hamel, J Moran, D Moher, ...
bmj 358, 2017
86452017
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
83562014
group P
D Moher, A Liberati, J Tetzlaff, DG Altman
Preferred reporting items for systematic reviews and meta-analyses: the …, 2009
7323*2009
SPIRIT 2013 statement: defining standard protocol items for clinical trials
AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ...
Annals of internal medicine 158 (3), 200-207, 2013
63602013
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
JAC Sterne, AJ Sutton, JPA Ioannidis, N Terrin, DR Jones, J Lau, ...
Bmj 343, 2011
62772011
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
D Moher, DJ Cook, S Eastwood, I Olkin, D Rennie, DF Stroup
The Lancet 354 (9193), 1896-1900, 1999
60991999
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
B Hutton, G Salanti, DM Caldwell, A Chaimani, CH Schmid, C Cameron, ...
Annals of internal medicine 162 (11), 777-784, 2015
60812015
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews
BJ Shea, JM Grimshaw, GA Wells, M Boers, N Andersson, C Hamel, ...
BMC medical research methodology 7, 1-7, 2007
53392007
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
AW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ...
Bmj 346, 2013
53212013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20